27 August 2019
Intelligent Ultrasound Group plc
("Intelligent Ultrasound" or the "Company")
Results of General Meeting, Open Offer and Total Voting Rights
Intelligent Ultrasound (AIM: MED), the intelligent ultrasound software and simulation company, is pleased to announce that at the General Meeting held earlier today, all resolutions proposed were duly passed by shareholders. Details of the votes cast by proxy will be published on the Company's website shortly.
Furthermore, the Open Offer closed for acceptances at 11.00 a.m. on 23 August 2019 with final valid applications from Qualifying Shareholders in respect of 869,043 Open Offer Shares including applications under the Excess Application Facility, representing a take-up of approximately 34.7 per cent. of the Open Offer Shares.
Accordingly, the Company will raise a total of approximately £6.3 million (before expenses) through the Placing and Open Offer through the issue and allotment of 63,369,043 new Ordinary Shares. An application has been made for 63,369,043 new Ordinary Shares to be admitted to trading on AIM, which is expected to take place at 8.00 a.m. on 28 August 2019.
Following Admission, the Company's issued share capital will comprise 219,996,792 Ordinary Shares, of which none are held in treasury. The above figure of 219,996,792 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the voting rights of the Company under the FCA's Disclosure Guidance and Transparency Rules.
Unless otherwise defined herein, capitalised terms used in this announcement shall have the same meanings as defined in the circular sent to shareholders of the Company on 8 August 2019.
Enquiries:
Intelligent Ultrasound Group plc |
|
Stuart Gall, CEO |
Tel: +44 (0)29 2075 6534 |
|
|
Cenkos Securities |
Tel: +44 (0)20 7397 8900 |
Giles Balleny/Cameron MacRitchie (Nominated Adviser) |
|
Michael Johnson/Julian Morse (Corporate Broking) |
|
|
|
Walbrook PR |
Tel: +44 (0)20 7933 8780 |
Anna Dunphy/Paul McManus |
Mob: +44 (0)7876 741 001/Mob: +44 (0)7980 541 893 |